Profil
Akihiro Furuta is currently the President & Representative Director at AskAt, Inc. Previously, he worked as the Director, Senior Head-Personnel & Operations at RaQualia Pharma, Inc. from 2012 to 2014.
He obtained his undergraduate degree from Oberlin College and Nagoya University.
Aktive Positionen von Akihiro Furuta
| Unternehmen | Position | Beginn |
|---|---|---|
AskAt, Inc.
 AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | Präsident | - |
Ehemalige bekannte Positionen von Akihiro Furuta
| Unternehmen | Position | Ende |
|---|---|---|
| RAQUALIA PHARMA INC. | Technik-/Wissenschafts-/F&E-Leiter | 08.06.2012 |
Ausbildung von Akihiro Furuta
| Nagoya University | Undergraduate Degree |
| Oberlin College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| RAQUALIA PHARMA INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
AskAt, Inc.
AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | Health Technology |
